MTHFR 677C →T and ACE D/I polymorphisms and migraine attack frequency in women

Cephalalgia

Volumn 30, Issue 4, 2010, Pages 447-456

  Schurks M ^a,b   Zee, R Y L ^a   Buring, J E ^a,c,d   Kurth, T ^a,c,e,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e INSERM   (France)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

ACE D I polymorphism; Attack frequency; Migraine; Migraine severity; MTHFR 677C T polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; RIBOFLAVIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; DIETARY INTAKE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE WITH AURA; MORBIDITY; ORAL CONTRACEPTION; PHYSICAL ACTIVITY; POSTMENOPAUSE; SELF REPORT; SMOKING; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MIGRAINE WITHOUT AURA; PHENOTYPE; RISK FACTOR; STATISTICAL MODEL;

FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77956260649     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01980.x     Document Type: Article

References (45)

1. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med 2005;118(Suppl. 1):S3-10.
2. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006;5:148-57.
3. Silberstein SD. Migraine. Lancet 2004;363:381-91.
4. Mulder EJ, Van Baal C, Gaist D, Kallela M, Kaprio J, Svensson DA, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 2003;6:422-31.
5. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 2003;4:386-98.
6. Tietjen EG. Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia 2007;27:981-7.
7. Tietjen GE. Migraine as a systemic disorder. Neurology 2007;68:1555-6.
8. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007;68:1563-70.
9. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
10. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007;167:795-801.
11. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-91.
12. Bottini F, Celle ME, Calevo MG, Amato S, Minniti G, Montaldi L, et al. Metabolic and genetic risk factors for migraine in children. Cephalalgia 2006;26:731-7.
13. de Tommaso M, Difruscolo O, Sardaro M, Losito L, Serpino C, Pietrapertosa A, et al. Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine. Headache 2007;47:253-65.
14. Ferro A, Castro MJ, Lemos C, Santos M, Sousa A, Pereira-Monteiro J, et al. The C677T polymorphism in MTHFR is not associated with migraine in Portugal. Dis Markers 2008;25:107-13.
15. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5, 10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003;111:84-90.
16. Kaunisto MA, Kallela M, Hamalainen E, Kilpikari R, Havanka H, Harno H, et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 2006;26:1462-72.
17. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000;96:762-4.
18. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2004;2:3.
19. Oterino A, Valle N, Pascual J, Bravo Y, Munoz P, Castillo J, et al. Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele. Brain Res Mol Brain Res 2005;139:163-8.
20. Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Dalla Volta G, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 2007;38:3145-51.
21. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006;59:372-5.
22. Schürks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C
23. Todt U, Freudenberg J, Goebel I, Netzer C, Heinze A, Heinze-Kuhn K, et al. MTHFR C677T polymorphism and migraine with aura. Ann Neurol 2006;60:621-2.
24. Joshi G, Pradhan S, Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J Neurol Sci 2009;277:133-7.
25. Cakmak EA, Cataloluk O, Yoldas T, Arslan A, Herken H, Barlas O, et al. Migraine and angiotensin-converting enzyme association in Turkish patients. Pain Clinic 2003;15:473-7.
26. Kara I, Ozkok E, Aydin M, Orhan N, Cetinkaya Y, Gencer M, et al. Combined effects of ACE and MMP-3 polymorphisms on migraine development. Cephalalgia 2007;27:235-43.
27. Kowa H, Fusayasu E, Ijiri T, Ishizaki K, Yasui K, Nakaso K, et al. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 2005;374:129-31.
28. Lea RA, Ovcaric M, Sundholm J, Solyom L, Macmillan J, Griffiths LR. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 2005;136:112-17.
29. Lin JJ, Wang PJ, Chen CH, Yueh KC, Lin SZ, Harn HJ. Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol Taiwan 2005;14:120-5.
30. Paterna S, Di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A, et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000;43:133-6.
31. Schürks M, Zee RYL, Buring JE, Kurth T. ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology 2009;72:650-6.
32. Tronvik E, Stovner LJ, Bovim G, White LR, Gladwin AJ, Owen K, Schrader H. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol 2008;8:4.
33. Tietjen GE, Herial NA, Utley C, White L, Yerga-Woolwine S, Joe B. Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia 2009; doi:10.1111/j.1468-2982.2008.01824. x.
34. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000;9:19-27.
35. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
36. Headache Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl. 7):1-96.
37. Schurks M, Buring JE, Kurth T. Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia 2009; doi:10.1111/j.1468-2982.2008.01835.x.
38. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999;9:936-49.
39. Zhang SM, Moore SC, Lin J, Cook NR, Manson JE, Lee IM, Buring JE. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol 2006;163:108-15.
40. Willett W. Nutritional epidemiology. New York: Oxford University Press, 1998.
41. Liew G, Wang JJ, Mitchell P. Migraine and coronary heart disease mortality: a prospective cohort study. Cephalalgia 2007;27:368-71.
42. Kurth T, Schürks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009; doi:10.1212/WNL. 0b013e3181ab2c20.
43. Kurth T, Ridker P, Buring J. Migraine and biomarkers of cardiovascular disease. Cephalalgia 2008;28:49-56.
44. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57.
45. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999;53:537-42.